The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

 

GlaxoSmithKline PLC

NYSE: GSK
Last

(U.S.) $41.25

Today's change+0.04 +0.10%
Updated August 28 4:02 PM EDT. Delayed by at least 15 minutes.
 

GlaxoSmithKline PLC

NYSE: GSK
Last

(U.S.) $41.25

Today's change+0.04 +0.10%
Updated August 28 4:02 PM EDT. Delayed by at least 15 minutes.

GlaxoSmithKline PLC up slightly

GlaxoSmithKline PLC closed up just (U.S.)$0.04 Friday to (U.S.)$41.25. Although unchanged over the last five days, shares are down 3.49% for the last year to date. This security has underperformed the S&P 500 by 15.20% during the last year.

Key company metrics

  • Open(U.S.) $40.56
  • Previous close(U.S.) $41.21
  • High(U.S.) $41.28
  • Low(U.S.) $40.56
  • Bid / Ask-- / --
  • YTD % change-3.49%
  • Volume2,739,493
  • Average volume (10-day)3,582,507
  • Average volume (1-month)4,266,143
  • Average volume (3-month)4,086,735
  • 52-week range(U.S.) $39.27 to (U.S.) $49.24
  • Beta0.76
  • Trailing P/E6.68×
  • P/E 1 year forward18.09×
  • Forward PEG2.21×
  • Indicated annual dividend(U.S.) $2.49
  • Dividend yield6.03%
  • Trailing EPS(U.S.) $6.17
Updated August 28 4:02 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+40.97%

Based on its net profit margin of 40.97%, GlaxoSmithKline PLC is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.71%Sector:Industry:
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2015Q1/2015Q4/2014Q3/2014
Fiscal Quarter Endvalues in $ millions unless otherwise notedJun 30, 201506/30/2015Mar 31, 201503/31/2015Dec 31, 201412/31/2014Sep 30, 201409/30/2014
Revenue5,8885,6226,1865,646
Total other revenue--------
Total revenue5,8885,6226,1865,646
Gross profit3,9933,7454,2783,894
Total cost of revenue1,8951,8771,9081,752
Total operating expense5,552-4,4375,4954,943
Selling / general / administrative2,1411,9511,9391,795
Research & development731789821742
Depreciation / amortization9131517
Interest expense (income), net operating--------
Unusual expense (income)838-8,990532738
Other operating expenses, total-62-77280-101
Operating income33610,059691703
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax1529,923531548
Income after tax1158,0381,025385
Income tax, total371,885-494163
Net income1498,0891,033401
Total adjustments to net income--------
Net income before extra. items1498,0891,033401
Minority interest3451816
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items1498,0891,033401
Inc. avail. to common incl. extra. items1498,0891,033401
Diluted net income1498,0891,033401
Dilution adjustment--------
Diluted weighted average shares4,8744,8204,8114,865
Diluted EPS excluding extraordinary itemsvalue per share0.031.680.210.08
Dividends per sharevalue per share0.190.190.230.19
Diluted normalized EPSvalue per share0.160.170.190.21